Skip to content
zameds

Bortezomib

Sold as Velcade, Bortezomib hetero, Valtib, Miblex, Bortrac, Velbor, Velbor iv, Botigen, Bertred, Bortezomib adco, Protecade, Betanuz, Devacad, Valoma, Zymib, Bortezomib zydus, Spalbort, Bortezomib eurolab, Bortezomib equity, Unizerib, Borturas, Onbort, Bortiv

S4

No structure available

This product's active ingredient could not be matched to a single known compound.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
16
Registrations
33
Schedule source
Consolidated Schedules 06 July 2026

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Janssen Pharmaceutica (Pty) LtdVelcade1 mg430427, A400005S4None
Hetero Drugs South Africa (Pty) LtdBortezomib hetero, Onbort, Bortiv1 mg/0,4 ml, 2,5 mg/1,0 ml, 3,5 mg, 3,5 mg/1,4 ml480121, 570409, 570410, 570411, 570412.0409, 570413.0410, 570414.0411S4None
Accord Healthcare (Pty) LtdValtib1,0 mg490891, 521027S4None
Eurolab (Pty) LtdMiblex, Bortezomib eurolab3.5 mg500093, 56/26/0602S4PIPIL
Activo Health (Pty) LtdBortrac3,5 mg500474S4None
Pharmacare limited û woodmeadCancelledVelborNot stated500568S4None
Mc Pharma (Pty) LtdCertificate held by Ruby Pharmaceuticals (Pty) LtdVelbor iv, Spalbort3,5 mg500960, 550759S4PIPIL
Ranbaxy Pharmaceutical (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) LtdBotigen3,5 mg510163S4PIPIL
Dr Reddyæs Laboratories (Pty) LtdCertificate held by Dr. Reddy’s Laboratories (Pty) Ltd.Bertred1, 3.5 mg510714, 550005S4PIPIL
Adcock Ingram Critical Care (Pty) LtdCertificate held by Adcock ingram critical careBortezomib adco, Protecade1 mg, 3,5 mg520727, 530177, 530178S4PIPIL
Aurogen South Africa (Pty) LtdCertificate held by Aurogen SA (Pty) LtdBetanuz, Devacad3,5 mg540081, 540082.081S4PIPIL
Juno Pharma SA (Pty) LtdValoma1, 2,5, 3,5540344, 540345, 540346S4None
Zydus Healthcare (Pty) LtdCertificate held by Zydus Healthcare SA (Pty) LtdZymib, Bortezomib zydus3,5 mg540834, 540835.834S4PIPIL
Equity Pharmaceutical (Pty) LtdCertificate held by Equity Pharmaceuticals (Pty) LtdBortezomib equity3.5 mg560040S4PIPIL
Ando Pharma (Pty) LtdUnizeribNot stated560643S4None
Pharma-q Holdings (Pty) LtdBorturas3,5 mg560790S4PIPIL

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Velcade 1 MG

EACH VIAL CONTAINS BORTEZOMIB 1,0 mg

1 mg43042743/26/0427RegisteredS4None
Bortezomib hetero 3,5 MG

EACH VIAL CONTAINS BORTEZOMIB 3,5 mg

3,5 mg48012148/26/0121RegisteredS4None
Valtib

EACH VIAL CONTAINS :BORTEZOMIB 3,5 mg

Not listed49089149/26/0891RegisteredS4None
Miblex

EACH VIAL CONTAINS BORTEZOMIB 3,5 mg

Not listed50009350/26/0093RegisteredS4None
Bortrac 3,5 MG

EACH VIAL CONTAINS BORTEZOMIB 3,5 mg

3,5 mg50047450/26/0474RegisteredS4None
Velbor

Each vial contains: Bortezomib 3,5 mg

Not listed50056850/26/0568CancelledS4None
Velbor iv

EACH VIAL CONTAINS: BORTEZOMIB 3,5 mg

Not listed50096050/26/0960RegisteredS4None
Botigen 3,5

Each vial contains: Bortezomib 3,5 mg

3,5 mgPowder for solution for injection51016351/26/0163Approved 27 January 2025RegisteredS4PIPIL
Bertred 3,5

EACH VIAL CONTAINS BORTEZOMIB 3,5 mg

3.5 mg.Lyophilised powder for solution for injection.51071451/26/0714Approved 24 March 2025RegisteredS4PIPIL
Bortezomib adco

Each vial contains: Bortezomib 3,5 mg

3,5 mgPowder for solution for injection52072752/26/0727Approved 30 August 2024RegisteredS4PIPIL
Valtib 1,0 MG

EACH VIAL CONTAINS: BORTEZOMIB 1,0 mg

1,0 mg52102752/26/1027RegisteredS4None
Protecade 1 MG

EACH VIAL CONTAINS BORTEZOMIB 1,0 mg

1 mg53017753/26/0177RegisteredS4None
Protecade 3,5 MG

EACH VIAL CONTAINS BORTEZOMIB 3,5 mg

3,5 mg53017853/26/0178RegisteredS4None
Betanuz

EACH VIAL CONTAINS BORTEZOMIB 3,5 mg

3,5 mgPowder for solution for injection54008154/26/0081Approved 20 June 2023RegisteredS4PIPIL
Devacad

EACH VIAL CONTAINS BORTEZOMIB 3,5 mg

3,5 mgPowder for solution for injection540082.08154/26/0082.081Approved 20 June 2023RegisteredS4PIPIL
Valoma 1

EACH VIAL CONTAINS BORTEZOMIB 1,0 mg

154034454/26/0344RegisteredS4None
Valoma 2,5

EACH VIAL CONTAINS BORTEZOMIB 2,5 mg

2,554034554/26/0345RegisteredS4None
Valoma 3,5

EACH VIAL CONTAINS BORTEZOMIB 3,5 mg

3,554034654/26/0346RegisteredS4None
Zymib

EACH VIAL CONTAINS BORTEZOMIB 3,5 mg

3,5 mgPowder for solution for injection54083454/26/0834Approved 10 September 2024RegisteredS4PIPIL
Bortezomib zydus

EACH VIAL CONTAINS BORTEZOMIB 3,5 mg

Not listed540835.83454/26/0835.834RegisteredS4None
Bertred 1

EACH VIAL CONTAINS BORTEZOMIB 1,0 mg

155000555/26/0005RegisteredS4None
Spalbort 3,5 MG

EACH VIAL CONTAINS: BORTEZOMIB 3,5 mg

3,5 mgLyophilised powder for solution for injection55075955/26/0759Approved 8 August 2023RegistreredS4PIPIL
Bortezomib 3,5 MG eurolab

EACH VIAL CONTAINS BORTEZOMIB 3,5 mg

3.5 mgPowder for solution for injection56/26/0602Approved 8 October 2024RegisteredS4PIPIL
Bortezomib equity

EACH VIAL CONTAINS BORTEZOMIB 3,5 mg

3.5 mgPowder for solution for injection56004056/26/0040Approved 25 April 2023RegisteredS4PIPIL
Unizerib

EACH VIAL CONTAINS BORTEZOMIB TRIMER EQUIVALENT TO BORTEZOMIB 3,5 mg

Not listed56064356/26/0643RegisteredS4None
Borturas 3,5 MG

EACH VIAL CONTAINS: BORTEZOMIB 3,5 mg

3,5 mgPowder for solution for injection56079056/26/0790Approved 20 August 2025RegisteredS4PIPIL
Onbort 1 mg/0,4 ML

EACH 0,4 ml SOLUTION CONTAINS: BORTEZOMIB 1,0 mg

1 mg/0,4 ml57040957/26/0409RegisteredS4None
Onbort 2,5 mg/1,0 ML

EACH 1,0 ml SOLUTION CONTAINS: BORTEZOMIB 2,5 mg

2,5 mg/1,0 ml57041057/26/0410RegisteredS4None
Onbort 3,5 mg/1,4 ML

EACH 1,4 ml SOLUTION CONTAINS: BORTEZOMIB 3,5 mg

3,5 mg/1,4 ml57041157/26/0411RegisteredS4None
Bortiv 1 mg/0,4 ML

EACH 0,4 ml SOLUTION CONTAINS: BORTEZOMIB 1,0 mg

1 mg/0,4 ml570412.040957/26/0412.409RegisteredS4None
Bortiv 2,5 mg/1,0 ML

EACH 1,0 ml SOLUTION CONTAINS: BORTEZOMIB 2,5 mg

2,5 mg/1,0 ml570413.041057/26/0413.410RegisteredS4None
Bortiv 3,5 mg/1,4 ML

EACH 1,4 ml SOLUTION CONTAINS: BORTEZOMIB 3,5 mg

3,5 mg/1,4 ml570414.041157/26/0414.411RegisteredS4None
Velcade

EACH VIAL CONTAINS BORTEZOMIB 3,5 mg

Not listedA400005A40/26/0005RegisteredS4None

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Bortezomib

  • S4: Bortezomib

    Consolidated Schedules 06 July 2026, line 5563

Pharmacological class: Cytostatic agents (class 26)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Botigen 3,5, Ranbaxy Pharmaceutical (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsBotigen 3,5, Ranbaxy Pharmaceutical (Pty) LtdPatient information leaflet (PIL)For patients and carersBotigen 3,5, Ranbaxy Pharmaceutical (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles